Andreas Bosio

Head of Molecular Technologies and Stem Cell Therapy

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andreas Bosio is the Head of Molecular Technologies and Stem Cell Therapy at Miltenyi Biotec B.V. & Co. KG in Germany. His research focuses on CAR T cell therapies for solid tumors and the role of neurodevelopmental genes in autism spectrum disorders. Recent publications include studies on the targeting of SSEA-4 in triple-negative breast cancer and the implications of NEUROD2 disruptions in glutamatergic neurons.

Articles (9)

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (18)

Surajit Sahu

Vrije Universiteit Brussel

BELGIUM

Andreas Bosio

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Targeting Stage-Specific Embryonic Antigen 4 (SSEA-4) in Triple Negative Breast Cancer by CAR T Cells Results in Unexpected on Target/off Tumor Toxicities in Mice

MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors.

Repolarization of HSC attenuates HSCs failure in Shwachman–Diamond syndrome

A roadmap for the Human Developmental Cell Atlas

ACSA‐2 and GLAST classify subpopulations of multipotent and glial‐restricted cerebellar precursors

Correction: Disruption of NEUROD2 causes a neurodevelopmental syndrome with autistic features via cell-autonomous defects in forebrain glutamatergic neurons (Molecular Psychiatry, (2021), 10.1038/s41380-021-01179-x)

Disruption of NEUROD2 causes a neurodevelopmental syndrome with autistic features via cell-autonomous defects in forebrain glutamatergic neurons.

Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma.

The Promise and the Hope of Gene Therapy.

Collaborators (18)

Surajit Sahu

Kathy Niakan

Bruce Aronow

Gary Bader

Jean‐Léon Maître

Pablo Gonzalez Camara

Emma Käller Lundberg

Deanne Taylor

Severine Mazaud-Guittot

M. Carolina Florian

Andrew Copp

Amanda Amoah

Alain Chédotal

Muzlifah Haniffa

Annalisa Buffo

Jarrett Camp

Antoine ROLLAND

Saadet Mercimek‐Andrews

Make your next move.